Recreational marijuana laws and the misuse of prescription opioids: Evidence from National Survey on Drug Use and Health microdata.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 277, doi. 10.1002/hec.4620
- By:
- Publication type:
- Article
Works matching IS 10579230 AND DT 2023 AND VI 32 AND IP 2
Results: 14
1
2
Public drug insurance, moral hazard and children's use of mental health medication: Latent mental health risk‐specific responses to lower out‐of‐pocket treatment costs.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 518, doi. 10.1002/hec.4631
- By:
- Publication type:
- Article
3
Assessing the impact of enforcement and compliance with minimum staffing standards on the quality of care in nursing homes: Evidence from the Centers for Medicare and Medicaid Services' staff star rating downgrade policy.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 235, doi. 10.1002/hec.4619
- By:
- Publication type:
- Article
4
Issue Information.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 233, doi. 10.1002/hec.4538
- Publication type:
- Article
5
The local health impacts of natural resource booms.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 462, doi. 10.1002/hec.4629
- By:
- Publication type:
- Article
6
Life expectancy and human capital: New empirical evidence.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 395, doi. 10.1002/hec.4626
- By:
- Publication type:
- Article
7
The effects of a national policy to reduce c‐sections in Brazil.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 501, doi. 10.1002/hec.4630
- By:
- Publication type:
- Article
8
Formal care of the elderly and health outcomes among adult daughters.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 436, doi. 10.1002/hec.4628
- By:
- Publication type:
- Article
9
Unintended health benefits of adopting preventive behaviors during a virus outbreak.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 324, doi. 10.1002/hec.4622
- By:
- Publication type:
- Article
10
More cost‐sharing, less cost? Evidence on reference price drugs.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 413, doi. 10.1002/hec.4627
- By:
- Publication type:
- Article
11
Parallel imports under a manufacturer rebate and a price freeze: Evidence from Germany.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 302, doi. 10.1002/hec.4621
- By:
- Publication type:
- Article
12
The impact of Community Health Centers on inappropriate use of emergency services.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 375, doi. 10.1002/hec.4625
- By:
- Publication type:
- Article
13
Informal caregiving, time use and experienced wellbeing.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 356, doi. 10.1002/hec.4624
- By:
- Publication type:
- Article
14
Impact of prevention in primary care on costs in primary and secondary care for people with serious mental illness.
- Published in:
- Health Economics, 2023, v. 32, n. 2, p. 343, doi. 10.1002/hec.4623
- By:
- Publication type:
- Article